NEW YORK (GenomeWeb News) – Response Genetics today announced it is joining Blue Shield of California's provider network, giving members of the health plan access to the Los Angeles-based molecular diagnostic firm's test portfolio.

The deal is Response Genetics' first contract with an affiliate of Blue Cross Blue Shield. Blue Shield of California has about 3 million members.

Among the products offered by Response Genetics are tests for colon, lung, gastric, and melanoma cancers, as well as tests for the detection of EGFR mutations, KRAS mutations, and others.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.